Severe COVID-19 as a virus-independent immunothrombotic process – Authors' reply

Dennis McGonagle, Abdulla Watad, Charles Bridgewood

Research output: Contribution to journal › Letter › peer-review

Access to Document

@article{6c10abac3bbb4a07ba935c4f8f8eeba5,

title = "Severe COVID-19 as a virus-independent immunothrombotic process – Authors' reply",

author = "Dennis McGonagle and Abdulla Watad and Charles Bridgewood",

year = "2022",

month = mar,

doi = "10.1016/S2665-9913(22)00031-5",

language = "אנגלית",

volume = "4",

pages = "e173",

journal = "The Lancet Rheumatology",

issn = "2665-9913",

publisher = "Elsevier Ltd.",

number = "3",

}

TY - JOUR

T1 - Severe COVID-19 as a virus-independent immunothrombotic process – Authors' reply

AU - McGonagle, Dennis

AU - Watad, Abdulla

AU - Bridgewood, Charles

PY - 2022/3

Y1 - 2022/3

UR - http://www.scopus.com/inward/record.url?scp=85125186573&partnerID=8YFLogxK

U2 - 10.1016/S2665-9913(22)00031-5

DO - 10.1016/S2665-9913(22)00031-5

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 35233541

AN - SCOPUS:85125186573

SN - 2665-9913

VL - 4

SP - e173

JO - The Lancet Rheumatology

JF - The Lancet Rheumatology

IS - 3

ER -